Recently, Synceres Biosciences completed A round of financing of nearly 100 million yuan for the R&D and operation of the company's new product pipeline, pilot test and team expansion.

Synceres is an international bio-tech company engaged in the frontier of synthetic biology related R&D. The company is co-founded by business elites and brilliant scientists with strong academic backgrounds. Synceres uses high-throughput synthetic bio-engineering technologies to provide innovative manufacturing solutions. Through systematic engineering at the level of molecular (DNA manipulation, direct evolution of enzymes etc.), cellular and sub-cellular (metabolic network rewriting and compartmentalization) and culturing (fermentation optimization), Synceres manages to commercialize the designed microbial cell factories for large-scale bio-manufacturing of various products. The market share is continuously expanding in the fields of biopharmaceuticals, tobacco, cosmetics, spices, fuel, solvent, and agriculture. 

At present, the lab testing of three pipelines of Synceres has been completed and is now entering into the pilot stage.